EGM
STRO icon

Engineers Gate Manager’s Sutro Biopharma STRO Stock Holding History

Engineers Gate Manager’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,072
Closed -$149K – 2391
2024
Q2 		$149K Sell
5,072
-2,985
-37% -$118K ﹤0.01% 1692
2024
Q1 		$455K Buy
8,057
+2,399
+42% +$106K 0.01% 1240
2023
Q4 		$243K Buy
+5,658
New +$180K 0.01% 1557
2023
Q2 		– Sell
-1,836
Closed -$84.8K – 2024
2023
Q1 		$84.8K Sell
1,836
-492
-21% -$31.2K ﹤0.01% 1524
2022
Q4 		$188K Buy
2,328
+349
+18% +$24.3K 0.01% 1393
2022
Q3 		$110K Buy
+1,979
New +$117K 0.01% 1439
2022
Q2 		– Sell
-1,380
Closed -$113K – 2250
2022
Q1 		$113K Buy
+1,380
New +$131K ﹤0.01% 1694
2021
Q3 		– Sell
-1,450
Closed -$270K – 1964
2021
Q2 		$270K Buy
+1,450
New +$284K 0.02% 1203
2021
Q1 		– Sell
-1,949
Closed -$423K – 2111
2020
Q4 		$423K Buy
+1,949
New +$323K 0.02% 1074

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Engineers Gate Manager's STRO Position: Q3 2024 in Review

Engineers Gate Manager sold out of Sutro Biopharma (STRO) in Q3 2024, closing a stake of 5,072 shares — an estimated $149K sold.

Engineers Gate Manager first reported a position in STRO in Q4 2020 and held it in 9 quarters. The position peaked at $455K in Q1 2024. 130 funds tracked by Wall St. Rank hold STRO as of Q3 2024.

  • Engineers Gate Manager reported no remaining Sutro Biopharma position as of Q3 2024 after selling out during the quarter.
  • Engineers Gate Manager sold 5,072 Sutro Biopharma shares in Q3 2024, an estimated $149K.
  • Engineers Gate Manager first reported a position in Sutro Biopharma in Q4 2020 and held it in 9 quarters.
  • Engineers Gate Manager's Sutro Biopharma position peaked at $455K in Q1 2024.
  • 130 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2024.

Based on Engineers Gate Manager's 13F filing for Q3 2024, filed 14 Nov 2024.